Abstract
Multiple sclerosis is associated with diverse behavioral changes. Rates of major depression approach 50% over the course of patients' lives, rates of bipolar disorder and psychosis are twice as common when compared to rates in the general population and pseudobulbar affect will afflict one in ten patients. However, these disorders often respond well to pharmacologic treatment and in the case of major depression, some forms of psychotherapy too. This article summarizes these mental state changes, their pathogenesis and treatment. Correct diagnosis and treatment can substantially improve the quality of life for MS patients.
Similar content being viewed by others
References
Asghar A, Taber KH, Hurley RA, Hayman LA (2004) Pure neuropsychiatric presentation of multiple sclerosis. Am J Psychiatry 161:226–231
Bakshi R, Czarnecki D, Shaikh ZA, Priore RL, Janardhan V et al. (2000) Brain MRI lesions and atrophy are related to depression in multiple sclerosis. NeuroReport 11:1153–1158
Beck AT, Steer RA, Brown GK (2000) BDI-Fast Screen for Medical Patients Manual. The Psychological Corporation, San Antonio, Tx
Benedict RH, Fishman I, McClellan MM, Bakshi R,Weinstock-Guttman B (2003) Validity of the Beck Depression Inventory-Fast Screen in multiple sclerosis. Multi Scler 9:393–396
Davison K, Bagley CR (1969) Schizophrenia- like psychoses associated with organic disorders off the central nervous system. A review of the literature. In: Herrington RN (ed) Current problems in neuropsychiatry. Hedley, Ashford, Kent, pp 113–184
Feinstein A (2000) Multiple sclerosis, depression and disease modifying drugs. Mult Scler 6:343–348
Feinstein A (2002) An examination of suicidal intent in patients with multiple sclerosis. Neurology 59:674–678
Feinstein A, du Boulay G, Ron MA (1992) Psychotic illness in multiple sclerosis.A clinical and magnetic resonance imaging study. Br J Psychiatry 161:680–685
Feinstein A, Feinstein KJ, Gray T, O'Connor P (1997) The prevalence and neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Arch Neurol 54:1116–1121
Feinstein A, O'Connor P, Gray T, Feinstein KJ (1999) The pathogenesis of pathological laughing and crying in multiple sclerosis: a role for the prefrontal cortex? Mult Scler 5:69–73
Feinstein A, Roy P, Lobaugh N, Feinstein KJ, O'Connor P (2004) Structural brain abnormalities in multiple sclerosis patients with major depression. Neurology 62:586–590
Flax JW, Gray J, Herbert J (1991) Effects of fluoxetine on patients with multiple sclerosis. Am J Psychiatry 148:1603
Joffe RT, Lippert GP, Gray TA, Sawa G, Horvath Z (1987) Personal and family history of affective disorder. J Affect Disord 12:63–65
Lynch SG. Kroencke DC, Denney DR (2001) The relationship between disability and depression in multiple sclerosis: the role of uncertainty, coping and hope. Mult Scler 7:411–416
Minden SL, Schiffer RB (1990) Affective disorders in multiple sclerosis: Review and recommendations for clinical research. Arch Neurol 47:98–104
Mohr DC, Boudewyn AC, Goodkin D, Bostrom A, Epstein L (2001) Comparative outcomes for individual cognitivebehavior therapy, supportive-expressive group therapy, and sertraline for the treatment of depression in multiple sclerosis. J Consult Clin Psychol 69:942–949
Panitch HS, Thisted RA, Smith RA, Wynn DR,Wymer JP et al. (2006) Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol 59:780–787
Patten SB, Beck CA, Williams JVA, Barbui C, Metz LM (2003) Major depression in multiple sclerosis. A population-based perspective. Neurology 61:1524–1527
Patten SB, Svenson LW, Metz LM (2005) Psychotic disorders in MS: Population-based evidence of an association. Neurology 65:1123–1125
Pujol J, Bello J, Deus J, Marti-Vilalta JL, Capdevila A (1997) Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis. Neurology 49:1105–1110
Rabins PV (1990) Euphoria in multiple sclerosis. In: Rao SM (ed) Neurobehavioral aspects of multiple sclerosis. Oxford University Press, New York, pp 180–185
Sadovnik AD, Eisen RN, Ebers GC, Paty DW (1991) Cause of death in patients attending multiple sclerosis clinics. Neurology 41:1193–1196
Schiffer RB, Herndon RM, Rudick RA (1983) Treatment of pathologic laughter and weeping with amitriptyline. NEJM 312:1480–1482
Schiffer RB, Wineman NM (1990) Antidepressant pharmacotherapy of depression associated with multiple sclerosis. Am J Psychiatry 147:1493–1497
Schubert RSB, Foliart RH (1993) Increased depression in multiple sclerosis: A meta-analysis. Psychosomatics 34:124–130
Seliger GM, Hornstein A, Flax J, Herbert J, Schroder K (1992) Fluoxetine improves emotional incontinence. Brain Inj 6:267–270
Stenager EN, Stenager E (1992) Suicide and patients with neurologic diseases. Methodologic problems. Arch Neurol 49:1296–1303
Author information
Authors and Affiliations
Corresponding author
Additional information
An erratum to this article is available at http://dx.doi.org/10.1007/s00415-008-0901-z.
Rights and permissions
About this article
Cite this article
Feinstein, A. Neuropsychiatric syndromes associated with multiple sclerosis. J Neurol 254 (Suppl 2), II73–II76 (2007). https://doi.org/10.1007/s00415-007-2017-2
Issue Date:
DOI: https://doi.org/10.1007/s00415-007-2017-2